US and European pharma groups benefit from cash-rich Chinese sector seeking new medicines
Related Posts
Australia's Private-Equity Deals for the New Year
*ST Zangge: Will the "mines" at home be willful? _Individual Stock Information_Market_CICC Online- CVC Capital Completes Acquisition of Da Niang Dumplings
Taiwan war games raise risk of US-China conflict
European stocks drop on trade worries
Myanmar’s refugees pose dilemma for China
Cathay Capital Invests In Chinese Furnishing Retailer ABS
Real estate to remain a growth lifeline for China through 2016
Hit Sci-Fi Novel- Europe’s New Appeasers